Delivery Order SPE2DB24D9113-SPE2DB24FEPXG
- Not listed
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued up to $499,999,999. The award, with a total ceiling value of $11,269.80 and a completion date of June 12, 2024, is for the supply of various pharmaceutical products, including flumazenil injections, prednisone tablets, ampicillin injections,...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract, with a ceiling value of $2,157, is for the delivery of various pharmaceutical products, including flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) valued at up to $499,999,999. The contract provides for the delivery of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued at up to $499,999,999. The contract is for the supply of a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued up to $499,999,999. The contract has no set-aside designation. Under this IDC, DMS Pharmaceutical Group will provide a comprehensive range of pharmaceutical products, from common medications to specialized drugs and medical supplies, to fulfill the...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract covers a wide range of pharmaceutical products, including common medications as well as specialized drugs and medical supplies, to fulfill the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA), Medical Supply Chain division, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,238.99 firm fixed-price delivery order is for the supply of various pharmaceutical items, including flumazenil injections, prednisone tablets, ampicillin injections, and other common and specialized medications. This award is part of a larger indefinite delivery contract (IDC) with DMS...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract is for the supply of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. The...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) for the supply of various pharmaceutical products, including medications such as flumazenil injections, prednisone tablets, ampicillin injections, and others. The contract, valued at up to $1,524.07, is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a significant indefinite...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of a variety of pharmaceutical products including flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs, and specialty medications. The award, valued at $2,189.20, is a firm fixed-price delivery order issued under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract...
- SPE2DB24D9113Indefinite Delivery Contract
- SPE2DB24D9113-SPE2DB24FEPXGDelivery Order
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued up to $499,999,999. The contract covers the delivery of various pharmaceutical products, including flumazenil injections, prednisone tablets, ampicillin injections, and specialized medications, to support the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The contract has a ceiling value of $9,948.88 and is a firm fixed-price arrangement with no set-aside designation. As a prime vendor for the DLA's Medical Supply Chain division, DMS Pharmaceutical Group plays a crucial role in the federal pharmaceutical supply chain, delivering both routine and critical medications to DoD healthcare facilities globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 9/24/24 |